| 000 | 02921cam a2200349 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223031115.0 | ||
| 008 | 141203s2014 ua d f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aPh.D | ||
| 099 | _aCai01.11.01.Ph.D.2014.Ha.N | ||
| 100 | 0 | _aHany Mohammed Elhadi Shoukat | |
| 245 | 1 | 0 |
_aN-acetylsysteine versus prostaglandin E1 as a renal protectivestrategy in infra renal aortic crossclamping surgery : _bA comparative study / _cHany Mohammed Elhadi Shoukat ; Supervised Mohammed Hany Kamal Eldin , Amany Kamal Alsawy , Sahar Sayed Ismael Badawy |
| 246 | 1 | 5 | _aدراسة مقارنة بين تأثير عقاري ال(إن أسيتيل سيستايين) و (بروستاجلاندين إيه وان) في حماية الكلى أثناء الجراحات التي تتطلب غلق الشريان الأورطي أسفل الكلى |
| 260 |
_aCairo : _bHany Mohammed Elhadi Shoukat , _c2014 |
||
| 300 |
_a124 Leaves : _bcharts ; _c25cm |
||
| 502 | _aThesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Anesthesia | ||
| 520 | _aObjectives: Our aim is to compare between the effects of intraoperative intravenous N-acetylsysteine infusion to intravenous prostaglandin E1 infusion for prevention of renal injury in patients undergoing abdominal aortic surgery with infrarenal aortic cross clamping. Patients & Methods: After approval of our Departmental Ethics and Research Committee, written informed consents were obtained from patients. Thirty patients were enrolled in the controlled randomized study. There were 26 male and 4 female patients with a mean age of 52.056 ±9.40 years scheduled for abdominal aortic surgery with infrarenal aortic cross-clamping with normal preoperative serum creatinine level (<1.5 mg/dl). ), patients were randomly assigned into three equal groupseach containing 10 patients as follows: Control group in which patients were received saline infusion at a rate of 2 ml/Kg/h after skin incision till 30 min after aortic de-clamping, NAC group in which patients were received N-acetylcysteine(FLUIMUCIL® 5g/25ml,Zambon)after skin incision at a dose of 150mg/kg infused in 20 min, followedby an infusion of 20 mg/kg/h till 30 min after aortic de-clamping, and PGE1 group in which patients were received PGE1 (PROSTIN*VR, 0.5mg/mL, Pfizer) after skin incision at a dose of 20 ng/Kg/min till 30 min after aortic de-clamping | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aAbdominal aortic aneurysm | |
| 653 | 4 | _aAbdominal aortic surgery | |
| 653 | 4 | _aAoro-occlusive disease | |
| 700 | 0 |
_aAmany Kamal Alsawy , _eSupervisor |
|
| 700 | 0 |
_aMohammed Hany Kamal Eldin , _eSupervisor |
|
| 700 | 0 |
_aSahar Sayed Ismael Badawy , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aAml _eCataloger |
||
| 905 |
_aNazla _eRevisor |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c48561 _d48561 |
||